Quality by design approach: Regulatory need
In this era of competition quality has been given prime magnitude; failure to meet such quality allied goals produces massive shift of company in share of market. In this context pharmaceutical industry is utmost regulated industry as it is governed by authoritative regulatory bodies. “Quality could...
Main Authors: | Jaiprakash N. Sangshetti, Mrinmayee Deshpande, Zahid Zaheer, Devanand B. Shinde, Rohidas Arote |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-05-01
|
Series: | Arabian Journal of Chemistry |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1878535214000288 |
Similar Items
-
Quality by Design Approach Using Multiple Linear and Logistic Regression Modeling Enables Microemulsion Scale Up
by: Michele Herneisey, et al.
Published: (2019-05-01) -
Formulation Approaches for Improving the Dissolution Behavior and Bioavailability of Tolvaptan Using SMEDDS
by: Jong-Hwa Lee, et al.
Published: (2022-02-01) -
AAPS Workshop: accelerating pharmaceutical development through predictive stability approaches, April 4–5, 2016
by: A. L. Freed, et al.
Published: (2017-09-01) -
QbD-mediated RP-UPLC method development invoking an FMEA-based risk assessment to estimate nintedanib degradation products and their pathways
by: Balaji Jayagopal, et al.
Published: (2020-09-01) -
Quality by Design (QbD) and Design of Experiments (DOE) as a Strategy for Tuning Lipid Nanoparticle Formulations for RNA Delivery
by: Lidia Gurba-Bryśkiewicz, et al.
Published: (2023-10-01)